|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 213/81 | (2006.01) |
| C07D 207/16 | (2006.01) | ||
| A61P 7/06 | (2006.01) | ||
| A61K 31/44 | (2006.01) |
| (11) | Number of the document | 3887356 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19805551.9 |
| Date of filing the European patent application | 2019-11-07 | |
| (97) | Date of publication of the European application | 2021-10-06 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2019/080511 |
| Date | 2019-11-07 |
| (87) | Number | WO 2020/108941 |
| Date | 2020-06-04 |
| (30) | Number | Date | Country code |
| 18208845 | 2018-11-28 | EP |
| (72) |
ADAMER, Verena , AT
THALER, Andrea , AT
SCHREINER, Erwin , AT
|
| (73) |
Sandoz AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | MULTI-COMPONENT CRYSTALS OF AN ORALLY AVAILABLE HIF PROLYL HYDROXYLASE INHIBITOR |
| MULTI-COMPONENT CRYSTALS OF AN ORALLY AVAILABLE HIF PROLYL HYDROXYLASE INHIBITOR |